SunPharma News
Shares of Sun Pharma settled 2.6 percent higher after the results and snapped six weeks of losses with a gain of 4.8 percent for the week.
The Mumbai-based drug major had produced the lot at its Halol-based manufacturing facility in Gujarat. The affected lot was later distributed in the market by its US-based unit.
Drug major Sun Pharmaceutical Industries on Wednesday said the US health regulator has accepted biologics licence application (BLA) for tildrakizumab for the treatment of psoriasis.
Loading...